I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Inflammation is the body defense reaction to eliminate or limit the spread of an injurious agent as well as to remove the consequently necrosed cells and tissues. Although inflammation is often undesirable, because an inflamed throat, skin or soft tissue can cause considerable discomfort, it is actually a beneficial and defensive phenomenon. The net result is the neutralization and elimination of an offending agent, the demolition of necrotic tissue and the establishment of conditions necessary for repair and restitution.\[[@CIT1]\]

Nonsteroidal and steroidal drugs are generally used to treat inflammation. However, these drugs have side-effects like nausea, vomiting, etc.\[[@CIT2]\] This led us to search for new anti-inflammatory agents from natural sources, which would be effective and safe. Many plant extracts show a synergistic effect with each other or with modern drugs. The extracts of *Solanum xanthocarpum* Schrad and Wendl and *Cassia fistula* Linn have been reported to possess anti-inflammatory activity.\[[@CIT3][@CIT4]\] We conducted this study to determine whether both these plant extracts showed increased anti-inflammatory activity at low dose when given in combination.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

Procurement and authentication of plant samples {#sec2-1}
-----------------------------------------------

Dried fruits of *Solanum xanthocarpum* and fruit pulp of *Cassia fistula* were procured from the local market in Mumbai and were authenticated at Nicholas Piramal Life Sciences, Mumbai. Fruits were powdered with a mechanical grinder and stored in an airtight container. The powdered drugs were tested for routine quality parameters like total ash, moisture content, sulfated ash, insoluble ash, etc.\[[@CIT5]\]

Preparation of plant extract\[[@CIT6]\] {#sec2-2}
---------------------------------------

Aqueous extraction of the powdered dried fruits of both the plants was carried out separately in a Soxhelet apparatus for 18 h. The extract was dried to a constant weight and kept under refrigeration. The extract obtained was standardized for parameters like %yield, color and consistency and used for further study.

Phytochemical screening of the extracts {#sec2-3}
---------------------------------------

Both the extracts were subjected to various tests to check the phytochemical constituents, viz. carbohydrates, glycosides, tannins, alkaloids, saponins, inorganic matter, etc.\[[@CIT5]\]

Anti-inflammatory study\[[@CIT7]--[@CIT10]\] {#sec2-4}
--------------------------------------------

Wistar Albino rats of either sex with body weight 150--300 g were used for the study. The animals were housed in cages under standard laboratory conditions (12-h light/dark cycle at 25° ± 2°C). They were allowed free access to a standard dry pellet diet (Hindustan Lever Ltd. Mumbai, India) and water *ad libitum*. All procedures described were reviewed and approved by the SNDT Women's University Animal Ethics Committee.

Animals were fasted overnight before administering the study drugs. Animals were divided into a total of six groups, as positive control, negative control, *Solanum xanthocarpum* group, *Cassia fistula* group, combination 1 and combination 2.

Diclofenac sodium at a dose of 150 mg/kg was administered to the positive control group animals. Oral single doses of individual plant extracts ranged from 100 to 500 mg/kg and a combination of both plant extracts were administered to the other group of animals, as shown in [Table 1](#T0001){ref-type="table"}.

###### 

Doses administered to animals

  ---------- -------------------------------------------------------------------------------
  Group 1:   Positive control
  Group 2:   Negative control
  Group 3:   *Solanum xanthocarpum* extract
             Subgroup 1: 6 animals administered 100 mg/kg *Solanum xanthocarpum* extract
             Subgroup 2: 6 animals administered 200 mg/kg *Solanum xanthocarpum* extract
             Subgroup 3: 6 animals administered 300 mg/kg *Solanum xanthocarpum* extract
             Subgroup 4: 6 animals administered 400 mg/kg *Solanum xanthocarpum* extract
             Subgroup 5: 6 animals administered 500 mg/kg *Solanum xanthocarpum* extract
  Group 4:   *Cassia fistula* extract
             Subgroup 1: 6 animals administered 100 mg/kg *Cassia fistula* extract
             Subgroup 2: 6 animals administered 200 mg/kg *Cassia fistula* extract
             Subgroup 3: 6 animals administered 300 mg/kg *Cassia fistula* extract
             Subgroup 4: 6 animals administered 400 mg/kg *Cassia fistula* extract
             Subgroup 5: 6 animals administered 500 mg/kg *Cassia fistula* extract
  Group 4:   Combination 1
             Subgroup 1: 6 animals administered 250 mg/kg SX extract and 50 mg CF extract
             Subgroup 2: 6 animals administered 250 mg/kg SX extract and 100 mg CF extract
             Subgroup 3: 6 animals administered 250 mg/kg SX extract and 150 mg CF extract
             Subgroup 4: 6 animals administered 250 mg/kg SX extract and 250 mg CF extract
  Group 4:   Combination 2
             Subgroup 1: 6 animals administered 250 mg/kg CF extract and 50 mg SX extract
             Subgroup 2: 6 animals administered 250 mg/kg CF extract and 100 mg SX extract
             Subgroup 3: 6 animals administered 250 mg/kg CF extract and 150 mg SX extract
  ---------- -------------------------------------------------------------------------------

SX: *Solanum xanthocarpum*, CF: *Cassia fistula*

After 30 min of the dose administration as shown in [Table 1](#T0001){ref-type="table"}, rats were challenged by subcutaneous injection of 0.1 ml of 1% solution of carrageenen into the planter side of the right hind paw. The paw volume was measured plethysmographically immediately after injection and again 1, 2, 3 and 4 h after challenge.

The increase of paw volume from 0 to 4 h was calculated as a percentage. The difference of average values between treated animals and control groups was calculated for each time interval and compared statistically.

The percentage inhibition was calculated according to the following formula:\[[@CIT9]\]

Percentage inhibition = 100 (1 - \[A - X/B - Y\])

where, A- mean paw volume of treated group after carrageenan injection.

B- mean paw volume of control group after carrageenan injection.

X- mean paw volume of treated group before carrageenan injection.

Y- mean paw volume of control group before carrageenan injection.

Isobolographic analysis of the response {#sec2-5}
---------------------------------------

The assessment of synergism is most often made from experiments in which an effect level is chosen and doses of drug A alone, drug B alone and the combination (a,b) that give this effect are determined experimentally. Doses that give the same effect are called isoboles and the method of analysis is an isobolographic method.

A measure of the synergism is made from the value of the interaction index. The index, denoted by γ, is defined by the isobolar relation.

Interaction index: a/A + b/B = γ

where, A = ED50 of *Solanum xanthocarpum* Schrad and Wendl

B = ED50 of *Cassia fistula* Linn

(a,b)= Dose of combination that shows ED50

The quantities in the above equation are obtained from the dose-response curves of drugs A, B and the combination.

If γ = 1, the interaction is additive,

if γ \<1, the interaction is synergistic and

if γ \>1, the interaction is antagonistic in nature.

Isobologram is plotted between dose of drug A and drug B. Doses that give a specified effect are joined, which is called as additivity line. Combinations are plotted on an isobologram: if that combination lies below the additivity line, it shows a synergistic activity and if it lies on the additivity line, it shows an additive activity. If it is beyond the additivity line, an antagonistic activity is indicated.\[[@CIT11]\]

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Phytochemical screening {#sec2-6}
-----------------------

The phytochemical analysis revealed the presence of carbohydrates, amino acids, proteins and anthraquinone glycosides in the *Cassia fistula* extract and carbohydrates, saponins, steroids, alkaloids, amino acids and proteins in the *Solanum xanthocarpum* extracts.

Anti-inflammatory study {#sec2-7}
-----------------------

The effects of both the extracts alone and in combination on paw edema induced by carrageenan are shown in [Table 2](#T0002){ref-type="table"}. Percentage inhibition of both the extracts and the combination at 300, 400 and 500 mg/kg dose is shown in [Table 3](#T0003){ref-type="table"} \[[Figure 1](#F0001){ref-type="fig"}\].

![Percentage inhibition of both plant extracts and the combination at the 300, 400 and 500 mg/kg doses](IJAR-1-167-g001){#F0001}

Isobolographic analysis {#sec2-8}
-----------------------

ED50 of both the plant extracts alone and at fixed ratios was assessed by an isobolographic analysis of the dose-response curves \[[Table 4](#T0004){ref-type="table"}; Figures [2](#F0002){ref-type="fig"}--[4](#F0004){ref-type="fig"}\]. The interaction index was found to be 0.64 for combination 1 and 0.88 for combination 2, which shows a synergistic activity.

![Dose response curve of *Solanum xanthocarpum* Schrad and Wendl](IJAR-1-167-g002){#F0002}

![Dose-response curve of *Cassia fistula* Linn](IJAR-1-167-g003){#F0003}

![Dose-response curve of combination 1 and combination 2](IJAR-1-167-g004){#F0004}

###### 

Percentage inhibition of *Solanum xanthocarpum* and *Cassia fistula* Linn alone and in combination at different doses

  Treatment              Doses (mg/kg)   Average paw volume of rats   Mean difference in fourth-hour paw volume (X)   Percentage inhibition                                               
  ---------------------- --------------- ---------------------------- ----------------------------------------------- ----------------------- ------ ------ -------------- -------------- -------
  Positive control                       1.11                         1.70                                            2.44                    2.73   2.45   1.34 ± 0.102   1.34 ± 0.249   81
  Negative control                       1.61                         1.62                                            1.85                    1.98   1.87   0.26 ± 0.063   0.26 ± 0.154   
  Solanum xanthocarpum   100             1.11                         1.56                                            1.91                    1.64   2.24   1.13 ± 0.099   1.13 ± 0.242   15.11
                         200             0.85                         1.51                                            1.79                    1.89   1.82   0.97 ± 0.049   0.97 ± 0.120   27.62
                         300             1.05                         1.49                                            1.97                    2.09   1.77   0.72 ± 0.051   0.72 ± 0.125   45.65
                         400             1.11                         1.56                                            1.91                    1.77   1.64   0.53 ± 0.035   0.53 ± 0.086   60.44
                         500             1.03                         1.58                                            1.76                    1.80   1.48   0.45 ± 0.026   0.45 ± 0.064   66.41
  Cassia fistula         100             1.56                         2.09                                            2.56                    2.10   2.53   0.97 ± 0.10    0.97 ± 0.245   27.6
                         200             1.48                         2.09                                            2.49                    2.40   2.38   0.90 ± 0.097   0.90 ± 0.238   32.26
                         300             1.67                         2.21                                            2.34                    2.46   2.42   0.75 ± 0.095   0.75 ± 0.233   43.81
                         400             1.43                         1.73                                            2.23                    2.20   2.11   0.68 ± 0.089   0.68 ± 0.218   48.74
                         500             0.97                         1.40                                            1.69                    1.84   1.55   0.58 ± 0.077   0.58 ± 0.189   56.90
  Combination 1          250 SX +50CF    1.67                         1.86                                            1.96                    2.28   2.26   0.59 ± 0.080   0.59 ± 0.196   55.72
                         250SX + 100CF   1.19                         1.59                                            1.99                    2.11   1.72   0.53 ± 0.072   0.53 ± 0.176   60.11
                         250SX + 150CF   1.56                         1.72                                            1.93                    2.03   1.97   0.41 ± 0.056   0.41 ± 0.137   69.49
                         250SX + 250CF   1.15                         1.22                                            1.39                    1.50   1.48   0.33 ± 0.038   0.33 ± 0.093   75
  Combination 2          250 CF+50SX     0.93                         1.15                                            1.81                    1.85   1.58   0.65 ± 0.079   0.65 ± 0.193   51.77
                         250 CF+100SX    0.97                         1.60                                            1.63                    1.72   1.57   0.60 ± 0.041   0.60 ± 0.1     54.88
                         250 CF+150SX    1.41                         1.87                                            2.09                    1.48   1.88   0.47 ± 0.053   0.47 ± 0.13    64.79

###### 

\% inhibition of Solanum xanthocarpum Schrad and Wendl and *Cassia fistula* Linn and of both combinations at 300, 400 and 500 mg/kg doses

  Plant extract          \% inhibition at the dose           
  ---------------------- --------------------------- ------- -------
  Solanum xanthocarpum   45.65                       60.44   66.41
  Cassia fistula         43.81                       48.74   56.90
  Combination 1          55.72                       69.49   75
  Combination 2          51.77                       64.79   75

###### 

ED50 of *Solanum xanthocarpum* and *Cassia fistula* extracts alone and in combination

  Plant extract          Equation               ED~50~ (mg/kg)
  ---------------------- ---------------------- ----------------
  Solanum xanthocarpum   Y = 76.727 X- 142.27   320.55
  Cassia fistula         Y = 41.651 X- 58.76    408.52
  Combination 1          Y = 91.233 X- 170.35   260.16
  Combination 2          Y = 109.96 X- 222.15   298.53

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

It was observed that extracts of *Solanum xanthocarpum* showed a higher anti-inflammatory activity than the extracts of *Cassia fistula* Linn. Both the extracts showed a maximum anti-inflammatory activity at the 500 mg/kg dose. Among different combinations of both the extracts, the 1:1 combination at the 500 mg/kg dose showed the maximum percentage inhibition of 75%, which was comparable with the positive standard diclofenac sodium that showed 81% inhibition.\[[@CIT10]\]

Synergistic effect was proved by isobolographic analysis. The doses of both the combinations showing a 50% effect were plotted on the isobolograms. The isobolograms as shown in [Figure 5](#F0005){ref-type="fig"} indicate that both the combinations fall below the additivity line, which shows that synergistic interactions occurred between *Solanum xanthocarpum* and *Cassia fistula* extract.

![Isobolographic plot for anti-inflammatory effect of *Solanum xanthocarpum* and *Cassia fistula* in combination](IJAR-1-167-g005){#F0005}

The interaction index of both the combinations was calculated, which found to be \<1. This indicated that both the extracts in combination show a better anti-inflammatory activity than when alone, which confirms the synergistic activity.

To conclude, percentage inhibition of both the extracts in combinations is higher than the individual plant extracts. The interaction index was also observed to be \<1. This showed that both the plant extracts were synergistic in nature.
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